Life Biosciences, Leading Developer of Therapeutics for Aging-Related Diseases, Completes $82 Million Series C Financing Round

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3JXl1Xx
via IFTTT